Developmental in Medical Technology

Autism Studies Presented at Mid-Atlantic Research Consortium Meeting

... (MAC) of the federally sponsored Intellectual and developmental Disabilities Research Centers (IDDRC). The ... committed to researching causes and treatments of developmental disabilities and mental retardation. "The goal of ... both diagnoses and outcomes for people with developmental disabilities," said Yudkoff, who is chief of ...

Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State

... birth defects, and autism spectrum and developmental disorders now approved for use on patients in New ... birth defects, and autism spectrum and developmental disorders, which conventional laboratory tests ... implicated in some types of mental retardation, developmental disorder and congenital anomalies, as well as in ...

New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions

... currently receiving funding from a state developmental disability agency WASHINGTON, Feb. 25 ... adults currently receiving funding from a state developmental disability agency. The study, titled, " Efficacy ... of the American Journal on Intellectual and developmental Disabilities (AJIDD). The SIS is a planning tool ...

Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community

... June 2008 issue of the journal, Intellectual and developmental Disabilities. To read "Successful Aging in ... extra copy of Chromosome 21. Intellectual and developmental Disabilities is among the top journals in special ... by the American Association on Intellectual and developmental Disabilities (http://www.aaidd.org ). Founded ...

Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology

... on ipilimumab treatment" (Abstract #3020, developmental Therapeutics: Immunotherapy Session) -- ... 4 doses (induction dosing)" (Abstract #3018, developmental Therapeutics: Immunotherapy Session) - Poster ... without prophylactic budesonide" (Abstract #3022, developmental Therapeutics: Immunotherapy Session) -- ...

St. Jude Defines Eye Cancer Gene's Role in Retinal Development

... eye cancer progresses. "A series of complex developmental processes must be carefully orchestrated for the ... member in the St. Jude Department of developmental Neurobiology. "One important aspect of this ... begin to understand the coordination of complex developmental programs in the developing eye and how these ...

Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children

... associated with up to 85 developmental disorders. A positive result may be confirmed ... for diagnosing patients suspected of having a developmental disorder. With better diagnostic insights, ... About Mental Retardation Mental retardation and developmental delay are characterized by significant ...

TRACON Pharmaceuticals' Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009

... Date and Time: Friday, May 29, 2009, 2:00 PM - 6:00 PM Session Title: developmental Therapeutics Session Type: Poster Discussion Abstract Number: ... and Time: Saturday, May 30, 2009, 8:00 AM - 12:00 PM Session Title: developmental Therapeutics Session Type: Poster Presentation Abstract Number: ...

Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting

... gene signature biomarker development. Abstract #3577; Poster Board #J19; developmental Therapeutics, May 30, 8:00 a.m.-12:00 p.m. Min P, et al. Small ... patients with advanced solid tumors. Abstract #2557; Poster Board #B18; developmental Therapeutics, May 30, 8:00 a.m.-12:00 p.m. About AT-101 AT-101 is ...

Lack of Food Variety Puts Kids With Autism at Risk for Poor Nutrition

... Zimmer, M.D., lead investigator and a pediatrician in the division of developmental and Behavioral Pediatrics at Cincinnati Children's. The study is one ... Researchers participating in studies were from the division of developmental and Behavioral Pediatrics and division of Neurology at Cincinnati ...

Study Finds Fever may Lead to Improved Behavior in Children with Autism Spectrum Disorders

... causes and cures of the disorder. Continued research and education about developmental disruptions in individuals with ASD is crucial, as early detection and ... Kennedy Krieger provides a wide range of services for children with developmental concerns mild to severe, and is home to a team of investigators who are ...

Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)

... Frank A. Lopez, M.D., neurodevelopmental pediatrician at the Children's developmental Center, Winter Park, Fla. "Importantly, this year- long study showed that ... L. Findling, M.D., John M. Turnbow, M.D., Jonathan Rubin, M.D. Children's developmental Center, Winter Park, FL; Western Psychiatric Institute and Clinic, ...

Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership

... disease. These discoveries are being translated into human therapeutics through an internal preclinical drug discovery effort coupled with further developmental activities with Novartis. Founded in 1999, the Institute is funded through the Novartis Research Foundation. About JDRF JDRF is a leader ...

Montefiore Medical Center and Albert Einstein College of Medicine Herald New Agreement To Continue Forty-Plus Year Historic Relationship

... centers at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Through its extensive ...

USC Keck School of Medicine's Dr. Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL-2 Molecule Therapeutic

... a viable candidate for expanded clinical evaluation. As a RAID award recipient, Dr. Epstein will receive access to drug development resources of the developmental Therapeutics Program. These resources will be used to further the preclinical development of his IL-2 analog therapy for the treatment of certain ...

In Rare Disorder, a Familiar Protein Disrupts Gene Function

... a gene array might also be developed as a single-platform tool to diagnose, from a patient's blood sample, not only CdLS, but also a variety of other developmental disorders. Funding for the study came from the National Institute of Child Health and Development of the National Institutes of Health, the ...

Clinical Data on Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, to be Presented at the 2009 ASCO Meeting

... refractory solid tumors Presenter: Elena G. Chiorean, MD Location: Level 2 - West Hall C. Poster Session Track: #79 developmental Therapeutics: Cytotoxic Chemotherapy; Poster Board B19 (Abstract # 2558) About SF1126 SF1126 is the only clinical stage ...

Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial

... later this year and in a subsequent Phase III efficacy study. "Enrollment of this second Phase II clinical trial represents another important developmental milestone for our VLP seasonal influenza vaccine program," said Dr. Rahul Singhvi, President and CEO of Novavax. "This study provides the opportunity ...

Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC

... ovarian cancer. Frantz BioMarkers, which has been granted exclusive worldwide rights to Moffitt's interests in the biomarkers, will pay initiation, developmental milestone and license maintenance fees, and royalties on sales. Moffitt and Frantz BioMarkers will collaborate on ovarian cancer biomarker research, ...

Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting

... Geoffrey P. Lewis, Ph.D. (along with G. Luna, J. Byun, E.A. Chapin and S.K. Fisher ) of the Neuroscience Research Institute and Molecular Cell & developmental Biology Department of the University of California, Santa Barbara , CA. has been accepted for publication in the journal Investigative Ophthalmology ...

D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients

... intended as an oral, disease-modifying therapy for Alzheimer's disease. Other mimics of bioactive lipids, LipidoMimetix, are at an earlier developmental stage, for cancer. For further information please contact: Tami Horovitz, PhD. Tel: +972-8-9385100 Fax: +972-8-9300795 Email: ...

Program Improves Language Skills in Deaf, Hard of Hearing

... to ensure that families follow up on initial screenings that indicate a possible problem with a more thorough evaluation," says Susan Wiley, MD, a developmental pediatrician at Cincinnati Children's and a co-author of the study. "Early intervention can and does have a great impact. We need to preserve ...

Autism Genes Discovered; Help Shape Connections Among Brain Cells

... understanding of how autism spectrum disorders arise, and may in time foster the development of strategies for prevention and early treatment," said developmental pediatrician Susan E. Levy, M.D., a co-author of both studies who is the medical director of the Regional Autism Center and a member of the Center ...

Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia

... Cancer Institute and at the Wayne State University School of Medicine's Department of Pediatrics. Dr. Xie is a Postdoctoral Fellow with the developmental Therapeutics Program at Karmanos Cancer Institute and Wayne State University School of Medicine. He also is a lecturer with the College of Life ...

AACR Data Highlights InNexus Preclinical Antibody Candidate

... is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of Mayo Clinic and has its own in-house developmental facilities. These development resources provide validation of protein and peptide discoveries, enabling InNexus (and its strategic partners) to ...

AndroScience Corporation Announces Phase 2a Study Results on ASC-J9(TM) for the Treatment of Acne

... SAN DIEGO, March 6 /PRNewswire/ -- AndroScience Corporation (ASC(TM)), a developmental stage pharmaceutical company announced results of a Phase 2a dose-ranging study of their lead clinical compound for the treatment of acne. The ...

Scientists Discover Why Teeth Form in a Single Row

... concerted actions of hundreds of genes to build a tooth, so it was amazing to find that deleting one gene caused the activation of a complete tooth developmental program outside of the normal tooth row in those mice. Finding out how the extra teeth developed will reveal how nature makes a tooth from scratch, ...

Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds

... levels, affecting 1 in 150 children, according to the Centers for Disease Control and Prevention. ASD include autism and related pervasive developmental disorders such as Asperger syndrome, Rett syndrome and childhood disintegrative disorder. Currently, there is no cure for the disorders, and ...

Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder

... of Cincinnati College of Medicine; Lori Altshuler, M.D., David Geffen School of Medicine at UCLA , Los Angeles; David Black, Ph.D., Pediatric and developmental Neuropsychiatry, National Institute of Mental Health (NIMH), National Institutes of Health (NIH), Bethesda, Md., and David Geffen School of Medicine ...

EntreMed Presents Initial Clinical Results for ENMD-2076

... Symposium on Anti-Angiogenic Agents held last week in San Diego, California. Dr. Diamond is a Hematology/Oncology Fellow, working in the developmental Therapeutics Program of the University of Colorado . (Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO ) Results from the ...

ExonHit Therapeutics Expands Strategic Collaboration With Allergan

... in the course of the collaboration with ExonHit. In return, ExonHit will receive from Allergan upfront payments as well as payments linked to developmental milestones and sales achievements. ExonHit will also be paid royalties on future sales. Detailed financial terms were not disclosed. ...

Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source

... and cancer stem cells in solid tissues like the intestine was not known," said Richard Gilbertson, M.D., Ph.D., associate member of the St. Jude developmental Neurobiology and Oncology departments and the paper's senior author. "Our work provides the first direct link between normal solid tissue stem cells ...

Brain Waves Show Sound Processing Abnormalities in Autistic Children

... revealed in the timing of brain activity," Dr. Roberts said. "We see a fraction of a second delay in autistic patients." Autism is a complex developmental disability that affects approximately one in every 150 American children, mostly boys, according to the Autism Society of America. Autism inhibits ...

12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions

... NanoThin Polyzene(R)-F. Neither product is currently approved for use in the United States. Other innovative devices are currently in the company's developmental pipeline. For more information, please visit http://www.celonova.com . ...

InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies

... is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of Mayo Clinic and has its own in- house developmental facilities. These development resources provide validation of protein and peptide discoveries, enabling InNexus (and its strategic partners) to ...

Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services

... to Athena Diagnostics, Inc. These patented tests include tests relating to: CADASIL, hearing loss related to A1555G or Connexin 26 mutations, developmental disorders caused by mutation of the ARX gene, Duchene's muscular dystrophy, myotonic dystrophy (DM1), Freidreich's Ataxia (FRDA), hereditary ...

Omega-3 Fatty Acids Critical to Infants, Mothers and the Seriously Ill

... level of prenatal DHA was linked to better outcomes, such as greater birth weight, gestational age, visual acuity, and higher mental and psychomotor developmental scores. "These studies do not justify ignoring contaminants in seafood, but they add to a large body of evidence that the benefits of eating ...

Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases

... asthma and chronic obstructive pulmonary disease. "Data on MT203 remain encouraging and we are pleased to reach this important developmental milestone," said Jens Hennecke, Micromet's Vice President of Business Development. "The MT203 program is well on track and we are looking forward to ...

Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center

... the US Food and Drug Administration (FDA) for commercial approval of the Delcath PHP System. About Delcath Systems, Inc. Delcath Systems is a developmental stage company testing its percutaneous perfusion technology for the isolated delivery of high doses of therapeutic and chemotherapeutic agents. The ...

Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO

... Oncology Research Program at the University of Chicago Medical Center, and a lead investigator in the trial, presented the data today in the developmental Therapeutics: Molecular Therapeutics oral abstract session (Abstract #3522) at the 44th Annual Meeting of the American Society of Clinical Oncology ...